The 2022 revision of EU GMP Annex 1 for sterile medicinal products has raised the bar for contamination control. It is no longer enough to have isolated procedures. Regulators now expect a holistic Contamination Control Strategy (CCS) that links facility design, personnel behaviour, environmental monitoring, and process validation.
Many pharmaceutical companies struggle to translate the Annex 1 requirements into a defendable audit position. Whether you are a manufacturer, a sponsor outsourcing sterile production, or a second party supplier, you need expert guidance to prepare for inspections.
GxP Cellators Consultancy offers specialized Annex 1 GMP auditing services. We help you achieve and maintain compliance for in-house operations, sponsor oversight, and supplier audits.
/eu-gmp-certification-requirements-sterile-manufacturing/
What Annex 1 Demands from Your Sterile Manufacturing
The regulation requires a documented CCS that defines all critical control points. It must include design controls, procedural measures, technical solutions, and organisational responsibilities. Sole reliance on terminal sterilisation or finished product sterility testing is not acceptable.
Key elements of the CCS include:
Facility and equipment design with qualification and validation
Personnel training, gowning qualification, and aseptic behaviour
Utility systems such as water, steam, and gases
Vendor approval for sterilisation services and single use systems
Cleaning and disinfection protocols
Environmental and process monitoring with trend analysis
Corrective and preventive actions (CAPA) based on root cause investigation
Annex 1 also demands specific attention to cleanroom grades. Grade A areas require continuous total particle monitoring. Any microbial growth in Grade A must trigger an immediate investigation. For aseptic processing, interventions must be listed, qualified, and simulated during media fills. Aseptic process simulations (APS) must be performed twice a year for each filling line and shift. Each operator must participate in at least one successful APS annually.
These requirements create significant audit risks if not properly implemented.
Three Types of Annex 1 Audits We Support
GxP Cellators provides flexible auditing services tailored to your role in the supply chain.
1. In-House Audits for Manufacturers
We assess your own sterile manufacturing facility against every module of Annex 1. Our auditors review your CCS, cleanroom qualification, use of barrier technology (isolators and RABS), utility monitoring, personnel gowning records, and aseptic process simulation data. We identify gaps before the regulator does.
2. Sponsor Audits of Contract Manufacturing Organisations (CMOs)
If you outsource sterile product manufacturing, you remain responsible for sterility assurance. We perform technical audits of your CMOs on your behalf. We verify their Annex 1 compliance, including sterilisation validation, filter integrity testing, bioburden controls, and environmental monitoring programmes. You receive a clear report with actionable findings.
3. Second Party Supplier Audits
Components, primary packaging materials, and single-use systems must meet the requirements of Annex 1. We audit your critical suppliers for contamination control, sterilisation processes, and quality management systems. We ensure that vendor approval is more than a paperwork exercise.
Why Choose GxP Cellators for Annex 1 Auditing Services
Our consultants are industry practitioners with direct experience in sterile manufacturing, quality assurance, and regulatory inspections. We do not just check boxes. We help you build a sustainable CCS that drives continuous improvement.
We use the actual Annex 1 guideline as our benchmark. We review airflow visualisation studies, video recordings, glove integrity testing frequencies, lyophilizer sterilisation intervals, and pre use post sterilisation integrity tests (PUPSIT) for filters. We understand the difference between alert levels and action limits and how to set them based on cleanroom qualification data.
Our reports are clear, concise, and prioritised by risk. We give you a roadmap to compliance.
How to Engage GxP Cellators for Your Annex 1 Audit
You can reach us through our website or by email.
Visit www.gxpcellators.com to learn more about our Annex 1 GMP auditing services, including in house audits, sponsor audits, and second party supplier audits.
Send inquiries to to schedule a preliminary discussion. We will understand your specific sterile manufacturing challenges and propose a tailored audit plan.
Do not wait for a regulatory finding. Let GxP Cellators help you turn Annex 1 compliance into a competitive advantage.
